G Persson. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh： See more » Administration, OralAdultAgedBlood Glucose/analysisCholesterol/bloodClinical Trials as TopicCyclohexanes/administration & dosageCyclohexanes/adverse effectsCyclohexanes/therapeutic useDiabetes Mellitus/drug therapyDiet, DiabeticDrug EvaluationElectrolytes/bloodFemaleGlycosuriaHumansHypoglycemic Agents/administration & dosageHypoglycemic Agents/adverse effectsHypoglycemic Agents/therapeutic useMaleMiddle AgedPhenformin/therapeutic usePlacebosPyrazines/administration & dosagePyrazines/adverse effectsPyrazines/therapeutic useSulfonylurea Compounds/administration & dosageSulfonylurea Compounds/adverse effectsSulfonylurea Compounds/therapeutic use
Substances： See more » Blood GlucoseCyclohexanesElectrolytesHypoglycemic AgentsPlacebosPyrazinesSulfonylurea CompoundsCholesterolPhenformin
Year: 1973 PMID： 4589635 DOI： 10.1007/bf01218445
Source DB: PubMed Journal: Diabetologia ISSN： 0012-186X Impact factor: 10.122